Kenison Michael R. 4

What Happened

• Michael R. Kenison, Chief Operations Officer of Proto Labs (PRLB), disposed of a total of 6,540 shares in mid‑February 2026. On Feb 13, 2026, 1,540 shares were surrendered (code F) at $67.52 per share to cover an exercise price or tax liability (value ≈ $103,981). On Feb 17, 2026, he sold 5,000 shares in open‑market transactions at a weighted average price of $66.46 per share (value ≈ $332,315). Combined proceeds across both transactions are about $436,300.
• These are sales (not purchases), which are often routine (e.g., tax withholding or plan‑based sales) rather than an explicit bullish signal.

Key Details

• Transaction dates and prices:
  • 2026-02-13: 1,540 shares disposed (code F) @ $67.52 — $103,981.
  • 2026-02-17: 5,000 shares sold (open market) weighted avg $66.46 (range $66.01–$66.87) — $332,315.
• Total shares disposed: 6,540; total proceeds ≈ $436,296.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes of note:
  • The Feb 17 sale was executed pursuant to a Rule 10b5‑1 trading plan adopted Aug 15, 2025 (pre‑arranged plan).
  • The Feb 17 amount is a weighted average of multiple trades; the filer can provide the per‑trade breakdown on request.
• Filing/Timeliness: Form 4 filed Feb 18, 2026. Given the transaction dates (Feb 13 and Feb 17), the filing appears to have been made within the standard reporting window.

Context

• The Feb 13 disposition (code F) indicates shares were surrendered to cover an exercise price or tax withholding—commonly seen with option exercises or vested awards where shares are withheld rather than cash paid.
• The Feb 17 sales were made under a pre‑existing 10b5‑1 plan, meaning they were pre‑scheduled and not necessarily a reaction to recent company developments.
• No purchases or grants were reported in this filing; these sales alone do not indicate management’s current view on company prospects.